BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 18165298)

  • 1. The type III toxins of Pseudomonas aeruginosa disrupt epithelial barrier function.
    Soong G; Parker D; Magargee M; Prince AS
    J Bacteriol; 2008 Apr; 190(8):2814-21. PubMed ID: 18165298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activities of Pseudomonas aeruginosa effectors secreted by the Type III secretion system in vitro and during infection.
    Lee VT; Smith RS; Tümmler B; Lory S
    Infect Immun; 2005 Mar; 73(3):1695-705. PubMed ID: 15731070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examining the role of actin-plasma membrane association in Pseudomonas aeruginosa infection and type III secretion translocation in migratory T24 epithelial cells.
    Bridge DR; Martin KH; Moore ER; Lee WM; Carroll JA; Rocha CL; Olson JC
    Infect Immun; 2012 Sep; 80(9):3049-64. PubMed ID: 22689823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the type III secreted exoenzymes S, T, and Y in systemic spread of Pseudomonas aeruginosa PAO1 in vivo.
    Vance RE; Rietsch A; Mekalanos JJ
    Infect Immun; 2005 Mar; 73(3):1706-13. PubMed ID: 15731071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pilT gene contributes to type III ExoS effector injection into epithelial cells in Pseudomonas aeruginosa.
    Shikata M; Hayashi N; Fujimoto A; Nakamura T; Matsui N; Ishiyama A; Maekawa Y; Gotoh N
    J Infect Chemother; 2016 Apr; 22(4):216-20. PubMed ID: 26809217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative contributions of Pseudomonas aeruginosa ExoU, ExoS, and ExoT to virulence in the lung.
    Shaver CM; Hauser AR
    Infect Immun; 2004 Dec; 72(12):6969-77. PubMed ID: 15557619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudomonas aeruginosa infection of airway epithelial cells modulates expression of Kruppel-like factors 2 and 6 via RsmA-mediated regulation of type III exoenzymes S and Y.
    O'Grady EP; Mulcahy H; O'Callaghan J; Adams C; O'Gara F
    Infect Immun; 2006 Oct; 74(10):5893-902. PubMed ID: 16988269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ezrin/radixin/moesin proteins are high affinity targets for ADP-ribosylation by Pseudomonas aeruginosa ExoS.
    Maresso AW; Baldwin MR; Barbieri JT
    J Biol Chem; 2004 Sep; 279(37):38402-8. PubMed ID: 15252013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ADP-ribosylation domain of Pseudomonas aeruginosa ExoS is required for membrane bleb niche formation and bacterial survival within epithelial cells.
    Angus AA; Evans DJ; Barbieri JT; Fleiszig SM
    Infect Immun; 2010 Nov; 78(11):4500-10. PubMed ID: 20732998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation of lasA and lasB reduces Pseudomonas aeruginosa invasion of epithelial cells.
    Cowell BA; Twining SS; Hobden JA; Kwong MSF; Fleiszig SMJ
    Microbiology (Reading); 2003 Aug; 149(Pt 8):2291-2299. PubMed ID: 12904569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The GAP portion of Pseudomonas aeruginosa type III secreted toxin ExoS upregulates total and surface levels of wild type CFTR.
    Tukaye DN; Kwon SH; Guggino WB
    Cell Physiol Biochem; 2013; 31(1):153-65. PubMed ID: 23428533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ADP-ribosyltransferase domain of the effector protein ExoS inhibits phagocytosis of Pseudomonas aeruginosa during pneumonia.
    Rangel SM; Logan LK; Hauser AR
    mBio; 2014 Jun; 5(3):e01080-14. PubMed ID: 24917597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impact of ExoS on
    Kroken AR; Chen CK; Evans DJ; Yahr TL; Fleiszig SMJ
    mBio; 2018 May; 9(3):. PubMed ID: 29717012
    [No Abstract]   [Full Text] [Related]  

  • 14. Pseudomonas aeruginosa and epithelial permeability: role of virulence factors elastase and exotoxin A.
    Azghani AO
    Am J Respir Cell Mol Biol; 1996 Jul; 15(1):132-40. PubMed ID: 8679217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential sensitivity of human epithelial cells to Pseudomonas aeruginosa exoenzyme S.
    McGuffie EM; Fraylick JE; Hazen-Martin DJ; Vincent TS; Olson JC
    Infect Immun; 1999 Jul; 67(7):3494-503. PubMed ID: 10377131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular heterogeneity of a type III cytotoxin, Pseudomonas aeruginosa exoenzyme S.
    Maresso AW; Riese MJ; Barbieri JT
    Biochemistry; 2003 Dec; 42(48):14249-57. PubMed ID: 14640693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of ZO-1, occludin, and actin in oxidant-induced barrier disruption.
    Musch MW; Walsh-Reitz MM; Chang EB
    Am J Physiol Gastrointest Liver Physiol; 2006 Feb; 290(2):G222-31. PubMed ID: 16239402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudomonas aeruginosa ExoS ADP-ribosyltransferase inhibits ERM phosphorylation.
    Maresso AW; Deng Q; Pereckas MS; Wakim BT; Barbieri JT
    Cell Microbiol; 2007 Jan; 9(1):97-105. PubMed ID: 16889625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exotoxin S secreted by internalized Pseudomonas aeruginosa delays lytic host cell death.
    Kroken AR; Gajenthra Kumar N; Yahr TL; Smith BE; Nieto V; Horneman H; Evans DJ; Fleiszig SMJ
    PLoS Pathog; 2022 Feb; 18(2):e1010306. PubMed ID: 35130333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudomonas aeruginosa ExoS and ExoT.
    Barbieri JT; Sun J
    Rev Physiol Biochem Pharmacol; 2004; 152():79-92. PubMed ID: 15375697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.